Open Access

Table 1

Clinical characteristic of the study subjects at study baseline.

Survivors (n = 26) Death (n = 24) P value
Age (yrs) 50.42 ± 12.63 62.04 ± 13.4 0.003
Men (%) 13 (50%) 8 (33.3%) 0.233
BMI (kg/m2) 23.64 ± 3.59 22.92 ± 3.23 0.462
Diabetes (%) 4 (15.3%) 16 (66.7%) <0.005
Hemoglobin (g/dl) 9.96 ± 1.46 9.96 ± 1.59 0.998
Albumin at stating PD (gm/dl) 3.61 ± 0.40 3.37 ± 0.4 0.045
Albumin averaged within 1st year of PD (gm/dl) 3.69 ± 0.32 3.16 ± 1.03 0.018
Calcium (mg/dl) 8.98 ± 0.60 8.93 ± 0.90 0.493
Phosphate (mg/dl) 5.29 ± 1.04 4.92 ± 1.46 0.316
Alkaline phosphatase 65.8 ± 32.1 81.2 ± 29.2 0.083
Intact PTH 390.8 ± 386.9 214.7 ± 202.1 0.052
nPCR 1.11 ± 0.25 1.02 ± 0.24 0.259
Transporters (H. HA. L. LA) 2.15.8.1 2.7.12.3 0.423
Total WCrCl (L/week/1.73m2) 75.14 ± 25.96 75.82 ± 23.41 0.922
Total Kt/V urea 2.06 ± 0.53 2.06 ± 0.4 0.997
Urine CCr 34.54 ± 26.27 37.97 ± 23.00 0.627
Urine Kt/V urea 0.7 ± 0.51 0.7 ± 0.37 0.977

BMI = Body mass index; Transporters. H. high, HA. high average, L. low, LA. low average; WCrCl = weekly creatinine clearance; K/t/V = urea clearance normalize to its volume distribution. PTH = parathyroid hormone; nPCR = normalized protein catabolic rate.